Adaptive Biotechnologies (ADPT) Other Operating Expenses (2018 - 2026)

Adaptive Biotechnologies has disclosed Other Operating Expenses across 9 years of filings, most recently posting $39.7 million for Q2 2026.

• In Q2 2026, Other Operating Expenses fell 5.37% year-over-year to $39.7 million; the TTM figure through Jun 2026 stood at $166.2 million (up 3.99% YoY), while the FY2025 annual figure was $166.8 million, up 1.88% from the prior year.
• Other Operating Expenses came in at $39.7 million for Q2 2026 at Adaptive Biotechnologies, down from $42.1 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $67.4 million in Q4 2023 to a low of $36.8 million in Q3 2022.
• Average Other Operating Expenses over 5 years is $42.2 million, with a median of $40.6 million recorded in 2022.
• Year-over-year, Other Operating Expenses surged 65.41% in 2023 and plunged 40.69% in 2024.
• Over 5 years, Other Operating Expenses stood at $40.7 million in 2022, then jumped by 65.41% to $67.4 million in 2023, then sank by 40.69% to $40.0 million in 2024, then rose by 5.93% to $42.3 million in 2025, then dropped by 6.12% to $39.7 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $39.7 million in Q2 2026, $42.1 million in Q1 2026, and $42.3 million in Q4 2025.